Icecure Medical Ltd Ord (ICCM)

$1.19 0.00 (0.00%)

16:00 EDT ICCM Stock Quote Delayed 30 Minutes

ICCM Stock Earnings: Icecure Medical Meets EPS, Beats Revenue for Q4 2023

By InvestorPlace Earnings Apr 3, 2024

ICCM stock results show that Icecure Medical met analyst estimates for earnings per share but beat on revenue for the fourth quarter of 2023.

5 Investors Betting Big on IceCure Medical (ICCM) Stock

7 Speculative Penny Stocks to Bet On This March

Why Is IceCure Medical (ICCM) Stock Up 300% Today?

More Articles

Volume:

Previous Close -

Market Cap -

PE Ratio -

EPS -

Volume (Avg. Vol.) 9,498

Day's Range -

52-Week Range $0.52 - $1.57

Dividend & Yield N/A (N/A)

ICCM Stock Predictions, Articles, and Icecure Medical Ltd Ord News

From InvestorPlace
From the Web

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday

By William White, InvestorPlace Writer Dec 20, 2022

We're starting off the day with a breakdown of the biggest pre-market stock movers traders need to know about on Tuesday morning!

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday

By William White, InvestorPlace Writer Nov 9, 2022

We're starting off the day with a breakdown of the biggest pre-market stock movers traders need to know about on Wednesday!

What Is Going on With IceCure Medical (ICCM) Stock Today?

By William White, InvestorPlace Writer Nov 8, 2022

IceCure Medical (ICCM) stock is taking off on Tuesday as investors react to an update for Medicare coverage of breast cancer patients.

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Friday

By William White, InvestorPlace Writer Oct 21, 2022

We're starting the final day of trading this week with a breakdown of the biggest pre-market stock movers for Friday morning!

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday

By William White, InvestorPlace Writer Sep 6, 2022

Good morning, trader! It's time to start off the day with a breakdown of the biggest pre-market stock movers for Tuesday morning!

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday

By William White, InvestorPlace Writer Apr 20, 2022

Another day of trading is waiting for investors and we're kicking it off with a look at the biggest pre-market stock movers for Wednesday!

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Monday

By William White, InvestorPlace Writer Feb 7, 2022

With a weekend of rest under our belts, we're ready to jump back into investing with the biggest pre-market stock movers for Monday!

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday

By William White, InvestorPlace Writer Feb 2, 2022

Good morning, investor! We're beginning another busy day of trading with a look at the biggest pre-market stock movers for Wednesday!

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday

By William White, InvestorPlace Writer Jan 20, 2022

Good morning, trader! It's time to dive into another day of investing with the biggest pre-market stock movers for Thursday!

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday

By William White, InvestorPlace Writer Oct 20, 2021

I hope you're ready for another busy day of trading because we're starting it with the biggest pre-market stock movers for Wednesday.

FDA agrees to review IceCure request for De Novo classification (NASDAQ:ICCM)

From Seeking Alpha Jan 30, 2024

FDA has agreed to review its denial of De Novo classification for IceCure's (ICCM) ProSense cryoablation system in the treatment of early stage breast cancer. Read more here.

IceCure Medical regains compliance with Nasdaq (NASDAQ:ICCM)

From Seeking Alpha Jan 12, 2024

IceCure Medical has regained compliance with Nasdaq's minimum bid price requirement, leading to a 4.55% increase in the company's shares in post-market...

IceCure shares rally 53% on ProSense kidney cancer study (NASDAQ:ICCM)

From Seeking Alpha Nov 28, 2023

IceCure (ICCM) shares rallied 53% after the company released encouraging results from a study of its ProSense cryoablation system in treating kidney cancer tumors. Read more here.

IceCure stock climbs 10% amid FDA appeal, earnings report (ICCM)

From Seeking Alpha Nov 15, 2023

IceCure Medical (ICCM) stock climbed 10% amid the release of its earnings report and news that it was appealing a recent FDA decision on its ProSense cryoablation technology.

Maxim Group Remains a Buy on IceCure Medical (ICCM)

From TipRanks Dec 7, 2022

In a report released yesterday, Anthony Vendetti from Maxim Group maintained a Buy rating on IceCure Medical (ICCM – Research Report), with a price...

IceCure Medical announces receipt of Nasdaq minimum bid price notification (NASDAQ:ICCM)

From Seeking Alpha Nov 3, 2023

IceCure Medical has received a notice from Nasdaq regarding non-compliance with minimum bid price requirement, with time until April 2024 to rectify the...

ADVERTISEMENT